Persistent symptoms and quality of life after novel coronavirus infection (COVID-19)

N. Lyubavina (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), M. Milyutina (Nizhny Novgorod, Russian Federation), E. Makarova (Nizhny Novgorod, Russian Federation), E. Galova (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), E. Nekaeva (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), I. Polyakova (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), N. Menkov (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), A. Egorskaya (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation)

Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19
Session: Clinical features and challenges of COVID-19
Session type: E-poster
Number: 296

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Lyubavina (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), M. Milyutina (Nizhny Novgorod, Russian Federation), E. Makarova (Nizhny Novgorod, Russian Federation), E. Galova (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), E. Nekaeva (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), I. Polyakova (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), N. Menkov (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation), A. Egorskaya (Nizhny NovgorodFederal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Russian Federation). Persistent symptoms and quality of life after novel coronavirus infection (COVID-19). 296

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of the novel coronavirus (COVID-19) pandemic on sleep
Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19
Year: 2021


Influenza vaccination in asthmatic children: effects on quality of life and symptoms
Source: Eur Respir J 2004; 24: 925-931
Year: 2004



The effect of the novel type coronavirus infection on the mental health of the patients
Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19
Year: 2021


Diffusion ability of the lungs in the assessment of respiratory function in patients who have undergone the new coronavirus infection (COVID-19)
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021


A much shorter core outcome set (COS) for measuring the health-related quality of life (HRQOL) effects of common acute respiratory symptoms
Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status
Year: 2021


Change in respiratory symptoms and health related quality of life in a community study
Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases
Year: 2005


Chronic cough, quality of life and the partner
Source: Annual Congress 2008 - Lung function, airways and cough
Year: 2008


Relations among questionnaire and laboratory measures of rhinovirus infection
Source: Eur Respir J 2006; 28: 358-361
Year: 2006



Respiratory impact and quality of life in patients with common variable immunodeficiency receiving subcutaneous IgG replacement therapy
Source: Annual Congress 2007 - Diagnostic tests and treatment in non cystic fibrosis bronchiectasis
Year: 2007



Pattern of self-reported (cough focus) symptoms across several respiratory virus- human challenge studies
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018




Impact of respiratory syncytial virus infection and palivizumab on severe acute lower respiratory infection during the first 6 months of life in a cohort of Colombian infants.
Source: International Congress 2018 – Clinical problems in paediatric pulmonology
Year: 2018

Serial viral infections in infants with recurrent respiratory illnesses
Source: Eur Respir J 2008; 32: 314-320
Year: 2008



Respiratory syncytial virus in adults: relationships between viral load, symptoms and lung function in an experimental infection model
Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections
Year: 2008

Sporadic coronavirus and human metapneumovirus lower respiratory tract infection in adults: comparison of chest CT findings and correlation with clinical outcomes
Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era
Year: 2020


Historical perspective: other human coronavirus infectious diseases, SARS and MERS
Source: Eur Respir Monogr 2021; 94: 28-38
Year: 2021


Lower respiratory tract illness due to rhinovirus in the first year of life
Source: Annual Congress 2007 - Bronchiolitis - viruses, treatment and outcome
Year: 2007


Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year
Source: Eur Respir J 2010; 35: 1022-1030
Year: 2010



Short-term survival of acute respiratory distress syndrome patients due to influenza virus infection alone: a cohort study
Source: ERJ Open Res, 6 (4) 00587-2020; 10.1183/23120541.00587-2020
Year: 2020



Determining clinically important change in health-related quality of life in survivors of acute respiratory distress syndrome
Source: Eur Respir J 2003; 22: Suppl. 45, 70s
Year: 2003

Psychological impact of chronic cough on quality of life
Source: Eur Respir J 2004; 24: Suppl. 48, 47s
Year: 2004